• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Arcus Biosciences Inc (NY: RCUS )

15.16 -0.40 (-2.57%)
Streaming Delayed Price Updated: 3:13 PM EST, Nov 5, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Arcus Biosciences Inc

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
12 Health Care Stocks Moving In Thursday's Pre-Market Session
November 18, 2021
Gainers Dicerna Pharmaceuticals (NASDAQ:DRNA) stock increased by 78.28% to $37.94 during Thursday's pre-market session. The market value of their outstanding shares is... 
Via Benzinga
Gilead Exercises Options to Three Arcus Biosciences Clinical-Stage Programs and Adds Research Collaboration
November 18, 2021
From Gilead Sciences, Inc.
Via Business Wire
Arcus Biosciences Announces New Employment Inducement Grants
November 09, 2021
From Arcus Biosciences, Inc.
Via Business Wire
The Daily Biotech Pulse: Merck Reports Positive Keytruda Readout, Moderna Slips Despite Q2 Beat, Bayer To Buy Vividion For Up To $2B, GlycoMimetics Gets New CEO
August 05, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 4) Absci, CORP (NASDAQ: ABSI) (... 
Via Benzinga
Recap: Arcus Biosciences Q3 Earnings
November 08, 2021
Arcus Biosciences (NYSE:RCUS) reported its Q3 earnings results on Monday, November 8, 2021 at 04:10 PM. Here's what investors need to know about the announcement. Earnings... 
Via Benzinga
Arcus Biosciences Reports Third Quarter 2021 Financial Results and Provides an Update on our anti-TIGIT Domvanalimab
November 08, 2021
From Arcus Biosciences, Inc.
Via Business Wire
Arcus Biosciences to Report Third Quarter 2021 Financial Results & Recent Corporate Highlights
November 02, 2021
From Arcus Biosciences, Inc.
Via Business Wire
Arcus Biosciences Announces New Employment Inducement Grants
October 26, 2021
From Arcus Biosciences
Via Business Wire
Earnings Scheduled For November 8, 2021
November 08, 2021
Companies Reporting Before The Bell • Privia Health Group (NASDAQ:PRVA) is projected to report quarterly loss at $0.11 per share on revenue of $215.14 million. •... 
Via Benzinga
Arcus Biosciences Announces New Employment Inducement Grants
October 11, 2021
From Arcus Biosciences
Via Business Wire
Arcus Biosciences Announces New Employment Inducement Grants
September 27, 2021
From Arcus Biosciences
Via Business Wire
Arcus Biosciences Announces New Employment Inducement Grants
September 09, 2021
From Arcus Biosciences, Inc.
Via Business Wire
Arcus Biosciences to Participate at Upcoming Investor Conferences
September 01, 2021
From Arcus Biosciences
Via Business Wire
Arcus Biosciences Announces New Employment Inducement Grants
August 24, 2021
From Arcus Biosciences, Inc.
Via Business Wire
Arcus Biosciences Announces New Employment Inducement Grants
August 10, 2021
From Arcus Biosciences, Inc.
Via Business Wire
Arcus Biosciences Reports Second Quarter 2021 Financial Results and Provides Operational Highlights
August 05, 2021
From Arcus Biosciences, Inc.
Via Business Wire
Arcus Biosciences to Participate at the 2021 Wedbush PacGrow Virtual Healthcare Conference
August 04, 2021
From Arcus Biosciences
Via Business Wire
Arcus Biosciences to Report Second Quarter 2021 Financial Results & Recent Corporate Highlights
July 29, 2021
From Arcus Biosciences
Via Business Wire
Arcus Biosciences Announces New Employment Inducement Grants
July 26, 2021
From Arcus Biosciences, Inc.
Via Business Wire
Arcus Surges As Executive Transfer Could Signal Deeper Gilead Partnership
July 20, 2021
An Arcus executive jumped ship for a role at Gilead, but RCUS stock popped Tuesday on expectations for a closer relationship. 
Via Investor's Business Daily
The Week Ahead In Biotech (Aug. 1-7): Biopharma Earnings Pick Up Pace, Eton Awaits FDA Decision, Focus On Pending Clinical Readouts and IPOs
August 01, 2021
Biotech stocks showed a lack of direction in the week ending July 30 amid earnings releases from big pharma companies. Most pharma majors reported strong quarterly results.... 
Via Benzinga
Exposures Product Safety
Arcus Biosciences Announces New Employment Inducement Grants
July 12, 2021
From Arcus Biosciences
Via Business Wire
Why Arcus Biosciences' Big Reveal Wasn't Very Exciting
June 25, 2021
No news from Arcus Biosciences is bad news for the company and other industry heavyweights. 
Via The Motley Fool
45 Biggest Movers From Yesterday
June 25, 2021
Gainers Marin Software Incorporated (NASDAQ: MRIN) shares surged 105.3% to close at $3.51 on Thursday after the company announced it has added the ability to manage Instacart Ads... 
Via Benzinga
Arcus Biosciences Announces New Employment Inducement Grants
June 24, 2021
From Arcus Biosciences
Via Business Wire
12 Health Care Stocks Moving In Thursday's Intraday Session
June 24, 2021
Gainers Pieris Pharmaceuticals (NASDAQ:PIRS) stock moved upwards by 27.11% to $4.5 during Thursday's regular session. As of 12:30 EST, this security is trading at a... 
Via Benzinga
36 Stocks Moving In Thursday's Mid-Day Session
June 24, 2021
Gainers Marin Software Incorporated (NASDAQ: MRIN) jumped 58% to $2.70 after the company announced it has added the ability to manage Instacart Ads to its flagship MarinOne... 
Via Benzinga
Here's Why Arcus Biosciences Stock Is Rising Today
June 24, 2021
Investors expecting Gilead Sciences to license Arcus Biosciences' lead asset could be in for an unpleasant surprise. 
Via The Motley Fool
Arcus Biosciences Rockets, But Vague Update In Cancer Study Divides Analysts
June 24, 2021
Arcus Biosciences offered a vague update on its lung cancer regimens Wednesday, but RCUS stock rocketed on Thursday. 
Via Investor's Business Daily
Mid-Morning Market Update: Markets Open Higher; Accenture Reports Upbeat Q3 Results
June 24, 2021
Following the market opening Thursday, the Dow traded up 0.76% to 34,130.38 while the NASDAQ rose 0.75% to 14,379.10. The S&P also rose, gaining 0.54% to 4,264.62. The U.S.... 
Via Benzinga
Topics Stocks
Exposures US Equities
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap